1. Home
  2. IRIX vs PMN Comparison

IRIX vs PMN Comparison

Compare IRIX & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • PMN
  • Stock Information
  • Founded
  • IRIX 1989
  • PMN 2004
  • Country
  • IRIX United States
  • PMN Canada
  • Employees
  • IRIX N/A
  • PMN N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • IRIX Health Care
  • PMN Health Care
  • Exchange
  • IRIX Nasdaq
  • PMN Nasdaq
  • Market Cap
  • IRIX 16.5M
  • PMN 16.0M
  • IPO Year
  • IRIX 1996
  • PMN N/A
  • Fundamental
  • Price
  • IRIX $1.12
  • PMN $0.63
  • Analyst Decision
  • IRIX
  • PMN Strong Buy
  • Analyst Count
  • IRIX 0
  • PMN 3
  • Target Price
  • IRIX N/A
  • PMN $4.33
  • AVG Volume (30 Days)
  • IRIX 172.5K
  • PMN 16.6M
  • Earning Date
  • IRIX 08-12-2025
  • PMN 08-13-2025
  • Dividend Yield
  • IRIX N/A
  • PMN N/A
  • EPS Growth
  • IRIX N/A
  • PMN N/A
  • EPS
  • IRIX N/A
  • PMN N/A
  • Revenue
  • IRIX $49,744,000.00
  • PMN N/A
  • Revenue This Year
  • IRIX $9.61
  • PMN N/A
  • Revenue Next Year
  • IRIX N/A
  • PMN N/A
  • P/E Ratio
  • IRIX N/A
  • PMN N/A
  • Revenue Growth
  • IRIX 0.09
  • PMN N/A
  • 52 Week Low
  • IRIX $0.78
  • PMN $0.38
  • 52 Week High
  • IRIX $2.14
  • PMN $1.59
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 42.12
  • PMN 48.21
  • Support Level
  • IRIX $1.27
  • PMN $0.77
  • Resistance Level
  • IRIX $1.34
  • PMN $0.73
  • Average True Range (ATR)
  • IRIX 0.08
  • PMN 0.09
  • MACD
  • IRIX -0.03
  • PMN -0.02
  • Stochastic Oscillator
  • IRIX 10.85
  • PMN 22.50

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: